The ability of GLP-1 to penetrate the BBB and exert a neuroprotective effect by reducing neuroinflammation, modulating amyloidogenesis, and reducing oxidative stress [51] suggests that this gut-produced hormone can be a potential treatment option for AD. Here, GLP1R is linked to Alzheimer disease.